Explanipedia
  • Topics
  • Tags
  • Collections

  • Books
  • Articles
  • Vids

  • About
  • Social
    Dr. Dan
    Dan's Personal Website
    Research, development & implementation
    All Social Links
  • Hot Topics
    Hot Topics
    Trending discussions and key themes
    Popular Tags
    Most used categories and labels
    Featured Collections
    Curated content groupings
    Active Channels
    Content streams and sources
    View All Topics...
  • Login
  1. Home
  2. Articles
  3. Authors
  4. Hayley C. Affronti

Hayley C. Affronti Uncle Sam recruitment poster (US) YOU? Author Swipe

View article: Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis Open
Phuong Nguyen, Michael H.I. Shiue, Nina Kuprasertkul, Pedro Costa‐Pinheiro, Luke Izzo , et al. · 2025
View article: A feedforward loop between ACLY and MYC supports T-ALL progression in vivo
A feedforward loop between ACLY and MYC supports T-ALL progression in vivo Open
Victoria da Silva-Diz, Amartya Singh, Maya Aleksandrova, Oekyung Kim, Christopher Thai , et al. · 2025
View article: ACLY alternative splicing correlates with cancer phenotypes
ACLY alternative splicing correlates with cancer phenotypes Open
Julianna Supplee, Hayley C. Affronti, Richard Duan, Rebekah Brooks, Zachary E. Stine , et al. · 2024
View article: Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis
Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis Open
Luke Izzo, Sophie Trefely, Christina Demetriadou, Jack M. Drummond, Takuya Mizukami , et al. · 2023
The metabolite acetyl-CoA is necessary for both lipid synthesis in the cytosol and histone acetylation in the nucleus. The two canonical precursors to acetyl-CoA in the nuclear-cytoplasmic compartment are citrate and acetate, which are pro…
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Supplementary Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis Open
Alessandro Carrer, Sophie Trefely, Steven Zhao, Sydney L. Campbell, Robert J. Norgard , et al. · 2023
Figures S1-S7 and Table S1
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis Open
Alessandro Carrer, Sophie Trefely, Steven Zhao, Sydney L. Campbell, Robert J. Norgard , et al. · 2023
Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis, and new strategies for prevention and treatment are urgently needed. We previously reported that histone H4 acetylation is elevated in pancreatic acinar cells harboring Kras
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Data from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Data from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Identifying and leveraging unique points of metabolic dysregulation in different disease settings is vital for safe and effective incorporation of metabolism-targeted therapies in the clinic. In addition, it has been shown identification o…
View article: Supplementary Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Supplementary Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis Open
Alessandro Carrer, Sophie Trefely, Steven Zhao, Sydney L. Campbell, Robert J. Norgard , et al. · 2023
Figures S1-S7 and Table S1
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Data from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Data from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Identifying and leveraging unique points of metabolic dysregulation in different disease settings is vital for safe and effective incorporation of metabolism-targeted therapies in the clinic. In addition, it has been shown identification o…
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Table from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy Open
Spencer R. Rosario, Justine J. Jacobi, Mark D. Long, Hayley C. Affronti, Aryn M. Rowsam , et al. · 2023
Supplementary Figure from JAZF1: A Metabolic Regulator of Sensitivity to a Polyamine-Targeted Therapy
View article: Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
Data from Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis Open
Alessandro Carrer, Sophie Trefely, Steven Zhao, Sydney L. Campbell, Robert J. Norgard , et al. · 2023
Pancreatic ductal adenocarcinoma (PDA) has a poor prognosis, and new strategies for prevention and treatment are urgently needed. We previously reported that histone H4 acetylation is elevated in pancreatic acinar cells harboring Kras




Generating Image
Download

Navigation

  • Home
  • Topics
  • Tags
  • Collections
  • Channels

Modules

  • Critical
  • Symbolic
  • Virtual
  • Narratics
  • Preprint
  • Reviewing

Social

  • YouTube
  • TikTok
  • Instagram
  • Twitter

Support

  • Patreon
  • About Us
  • FAQ
  • Contact
  • Privacy Policy
  • Terms of Service
© 2025 Explanipedia. All Rights Reserved.







Fetching topic information...